Showing results (661-670 of 751) with videos related to

Sort By:
Pageof 76
ACS Nano|March 13, 2012
Lithographically defined three-dimensional graphene structuresXiaoyin Xiao, Thomas E Beechem, Michael T Brumbach, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 24, 2025
Mixed Methods Randomized Controlled Trial Comparing Quality of Life for Pregnant Women With Type 1 Diabetes Using Hybrid Closed-Loop to Sensor-Augmented Pump TherapyElizabeth O Buschur, Julia Reedy, Cari Berget, et al.
Plos Pathogens|June 8, 2018
EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairmentChao-Jiang Gu, Alejandra Borjabad, Eran Hadas, et al.
Plos One|January 6, 2011
A phase II trial of sorafenib in metastatic melanoma with tissue correlatesPatrick A Ott, Anne Hamilton, Christina Min, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanomaDavid B Solit, Iman Osman, David Polsky, et al.
Communications Biology|October 31, 2018
Extraction and biomolecular analysis of dermal interstitial fluid collected with hollow microneedlesPhilip R Miller, Robert M Taylor, Bao Quoc Tran, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2003
A framework for vulnerability analysis in sustainability scienceB L Turner, Roger E Kasperson, Pamela A Matson, et al.
Archives of Dermatology|April 23, 2008
Utility of lesion diameter in the clinical diagnosis of cutaneous melanomaNaheed R Abbasi, Molly Yancovitz, Dina Gutkowicz-Krusin, et al.
Life Science Alliance|July 26, 2023
Human TLR8 induces inflammatory bone marrow erythromyeloblastic islands and anemia in SLE-prone miceNaomi I Maria, Julien Papoin, Chirag Raparia, et al.
Oncology|June 12, 2017
Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of CareChloe Goldman, Jeremy Tchack, Eric M Robinson, et al.
Pageof 76